BSECompany Update3 Aug 2026 · 3 Aug 2026, 04:58 pm
Enclosed herewith Resignation of Mr. Pankaj Jashwant Shah from post of Managing Director and Chief Executive Officer with effect from 03.08.2026
Aspira Pathlab & Diagnostics Ltd · 540788
✦ AI SummaryMgmt Change
Aspira Pathlab & Diagnostics Ltd has announced the resignation of Mr. Pankaj Jashwant Shah as Managing Director and Chief Executive Officer, effective August 3, 2026, due to personal reasons.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO)
Attachments (1)
📄pdf
Download →
0c064d70-ee60-41a5-ad86-a826b49be818.pdf
View document text
Aspira Pathlab & Diagnostics Limited
Regd. Office: Flat No. 2, R D Shah Building, Shraddhanand
Road, Opp. Railway Station, Ghatkopar (W), Mumbai 400 086
Corporate Office: 6 & 7, Bhaveshwar Arcade, Near Shreyas
Junction LBS Marg, Behind Saraswat Bank, Ghatkopar (W),
Mumbai-400086
CIN: L85100MH1973PLC289209
Date: August 03, 2026
BSE Limited,
Listing Department
Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai-400001.
Security Code: 540788
Security ID: ASPIRA
Sub: Resignation from the post of Managing Director and Chief Executive Director
Ref:Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements)
Regulations, 2015
Dear Sir/Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 (‘SEBI LODR’) we wish to inform you that Mr. Pankaj Jashwant Shah (DIN:
02836324), has tendered his resignation as Managing Director and Chief Executive Director
due to personal reasons with immediate Effect i.e. 03.08.2026.
The details as required under Regulation 30 of Listing Regulations read with SEBI Master
Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January 2026 are
provided in Annexure-I.
Kindly take the same on record.
Thanking you.
Yours Faithfully,
For Aspira Pathlab & Diagnostics Limited
Nikunj Mange
Executive Director
DIN: 08489442
INDIA’S FIRST
0227197 5756, 022 2513 9090 www.aspiradiagnostics.com
FULLY INTEGRATED LAB support@aspiradiagnostics.com │info@aspiradiagnostics.com
Aspira Pathlab & Diagnostics Limited
Regd. Office: Flat No. 2, R D Shah Building, Shraddhanand
Road, Opp. Railway Station, Ghatkopar (W), Mumbai 400 086
Corporate Office: 6 & 7, Bhaveshwar Arcade, Near Shreyas
Junction LBS Marg, Behind Saraswat Bank, Ghatkopar (W),
Mumbai-400086
CIN: L85100MH1973PLC289209
Annexure-1
Disclosure of information pursuant to Regulation 30 of Listing Regulations read with SEBI
Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January 2026.
Sr Particulars Disclosure
1. Reason for change viz. Mr. Pankaj Jashwant Shah, (DIN:
appointment, re-appointment, 02836324) has tendered
resignation, removal, her resignation from the
death or otherwise; post of Managing Director
and Chief Executive
Director
due to personal reasons.
2. Date of cessation August 03, 2026.
3. Brief Profile Not applicable
4. Disclosure of relationships Not applicable
between Directors
INDIA’S FIRST
0227197 5756, 022 2513 9090 www.aspiradiagnostics.com
FULLY INTEGRATED LAB support@aspiradiagnostics.com │info@aspiradiagnostics.com